nivolumabpembrolizumab
…city, with G3/4 events reported in 22% compared with 14% in the nivolumab monotherapy arm. An update presented at the European Society of…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…city, with G3/4 events reported in 22% compared with 14% in the nivolumab monotherapy arm. An update presented at the European Society of…
…mFOLFOX6 plus atezolizumab 840 mg Q2W for 12 cycles followed by atezolizumab monotherapy Q3W for 13 cycles (experimental). The primary end-p…